Unlabelled: Recent studies have revealed that the wild-type hemochromatosis protein (HFE) interacts with the transferrin receptor (TfR) and modulates TfR-mediated iron uptake by cells. Because of similarities in the transport of gallium and iron and the use of (67)Ga scanning in lymphoid malignancies, we examined the effect of HFE expression on (67)Ga uptake.
Methods: (67)Ga and (59)Fe uptakes were measured in HeLa cells transfected with a FLAG-tagged wild-type HFE (fHFE) gene under control of a tetracycline-repressible promoter. fHFE and TfR protein levels were measured by Western blotting; cellular transferrin (Tf) binding sites were measured by (125)I-Tf binding assay.
Results: Induction of fHFE expression produced an increase in TfR protein that was accompanied by a decrease, rather than an increase, in cellular (67)Ga and (59)Fe uptake. The difference in (67)Ga uptake between fHFE-expressing and fHFE-nonexpressing cells was markedly increased in the presence of Tf. Although fHFE expression produced an increase in cellular TfR protein, cell surface and intracellular Tf binding sites were actually decreased in these cells.
Conclusion: Our studies suggest that expression of wild-type HFE in cells produces a decrease in (67)Ga uptake due to a reduction in available Tf binding sites for (67)Ga-Tf on the TfR. These results imply that (67)Ga uptake by cells with wild-type HFE may differ from cells with the HFE C282Y mutation.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Recurrent BMP4 variants in exon 4 cause non-HFE-associated hemochromatosis via the BMP/SMAD signaling pathway.
Orphanet J Rare Dis
November 2024
Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Background: Hereditary hemochromatosis (HH) is an iron overload disorder and can be caused by variants in non-HFE genes in Chinese patients. However, there is still a considerable proportion of patients suffering from unexplained iron overload. In our previous study, we had identified the p.
View Article and Find Full Text PDFEffects of iron overload in human joint tissue explant cultures and animal models.
J Mol Med (Berl)
November 2024
Hepatogenomics Research Group, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, Qld, 4059, Australia.
Osteoarthritis (OA) is a prevalent degenerative joint disease affecting over 530 million individuals worldwide. Recent studies suggest a potential link between iron overload, a condition characterised by the excessive accumulation of iron in the body, and the onset of OA. Iron is essential for various biological processes, and any disruption in its homeostasis can trigger significant health effects, including OA.
View Article and Find Full Text PDFThe oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis.
Hemasphere
September 2024
Research Zurich, CSL R&D Schlieren Switzerland.
Article Synopsis
- * The study tested an oral ferroportin inhibitor called vamifeport in a mouse model (C282Y) that mimics the most common genetic mutation in humans with hemochromatosis, finding that it effectively lowered iron levels in the bloodstream and liver.
- * Chronic treatment with vamifeport not only maintained lower iron levels but did so without hindering the effects of phlebotomy, suggesting it could be a viable therapy for hemochromatosis patients who undergo iron removal.
Liraglutide Impacts Iron Homeostasis in a Murine Model of Hereditary Hemochromatosis.
Endocrinology
July 2024
Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
Classic hereditary hemochromatosis (HH) is an autosomal recessive iron-overload disorder resulting from loss-of-function mutations of the HFE gene. Patients with HH exhibit excessive hepatic iron accumulation that predisposes these patients to liver disease, including the risk for developing liver cancer. Chronic iron overload also poses a risk for the development of metabolic disorders such as obesity, type 2 diabetes, and insulin resistance.
View Article and Find Full Text PDFCommon Mutation in the Gene Modifies Recovery After Intracerebral Hemorrhage.
Stroke
November 2023
Department of Neurosurgery (T.B.H., K.P., E.B.N., B.S.-W., S.D.S., J.R.C.), Penn State College of Medicine, Hershey, PA.
Background: Intracerebral hemorrhage (ICH) is characterized by bleeding into the brain parenchyma. During an ICH, iron released from the breakdown of hemoglobin creates a cytotoxic environment in the brain through increased oxidative stress. Interestingly, the loss of iron homeostasis is associated with the pathological process of other neurological diseases.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!